Alfuzosin (Standard)
Alfuzosin (Standard) is the analytical standard of Alfuzosin. This product is intended for research and analytical applications. Alfuzosin (SL 77499-10) is an orally active, selective and competitive α1-adrenoceptor antagonist. Alfuzosin relaxes the muscles of the prostate and bladder neck, aiding in urination. Alfuzosin can be used in study of benign prostatic hyperplasia (BPH) [1][2].
Product Specifications
CAS Number
[81403-80-7]
Product Name Alternative
SL 77499 (Standard)
UNSPSC
12352100
Target
Adrenergic Receptor; Reference Standards
Related Pathways
GPCR/G Protein; Neuronal Signaling; Others
Field of Research
Endocrinology
Smiles
O=C(C1OCCC1)NCCCN(C2=NC(N)=C3C=C(OC)C(OC)=CC3=N2)C
Molecular Formula
C19H27N5O4
Molecular Weight
389.45
References & Citations
[1]Martin DJ, et al. Relationship between the effects of alfuzosin on rat urethral and blood pressures and its tissue concentrations. Life Sci. 1998;63 (3) :169-76. |[2]Wilde MI, et al. Alfuzosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in benign prostatic hyperplasia. Drugs. 1993 Mar;45 (3) :410-29.
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
Clinical Information
Launched
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
C2069-50P-ML650 100 µL
Catenin, beta, phosphorylated (Ser37) (catenin (cadherin-associated protein), beta 1, 88kD, beta-catenin, Beta-catenin, Catenin beta-1, CTNNB, DKFZp686D02253, FLJ25606, FLJ37923, OK/SW-cl.35, PRO2286) (MaxLight 650) discontinued
Ask
View Details 
MBS6275993-01 0.1 mL
ATG13, Phosphorylated (S355) (ATG13, KIAA0652, Autophagy-related protein 13) (MaxLight 650)
Ask
View Details 
MBS6275993-02 5x 0.1 mL
ATG13, Phosphorylated (S355) (ATG13, KIAA0652, Autophagy-related protein 13) (MaxLight 650)
Ask
View Details